SABRA HEALTH CARE REIT INC (SBRA) Fundamental Analysis & Valuation

NASDAQ:SBRA • US78573L1061

Current stock price

19.775 USD
+0.04 (+0.23%)
Last:

This SBRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. SBRA Profitability Analysis

1.1 Basic Checks

  • SBRA had positive earnings in the past year.
  • SBRA had a positive operating cash flow in the past year.
  • In multiple years SBRA reported negative net income over the last 5 years.
  • SBRA had a positive operating cash flow in each of the past 5 years.
SBRA Yearly Net Income VS EBIT VS OCF VS FCFSBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M

1.2 Ratios

  • SBRA's Return On Assets of 2.83% is fine compared to the rest of the industry. SBRA outperforms 72.36% of its industry peers.
  • SBRA has a better Return On Equity (5.51%) than 67.48% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.88%, SBRA is in the better half of the industry, outperforming 71.54% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SBRA is in line with the industry average of 3.13%.
  • The last Return On Invested Capital (3.88%) for SBRA is above the 3 year average (3.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.83%
ROE 5.51%
ROIC 3.88%
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
SBRA Yearly ROA, ROE, ROICSBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • Looking at the Profit Margin, with a value of 20.09%, SBRA is in the better half of the industry, outperforming 72.36% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SBRA has declined.
  • SBRA has a Operating Margin of 34.06%. This is in the better half of the industry: SBRA outperforms 70.73% of its industry peers.
  • In the last couple of years the Operating Margin of SBRA has declined.
  • The Gross Margin of SBRA (66.87%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of SBRA has declined.
Industry RankSector Rank
OM 34.06%
PM (TTM) 20.09%
GM 66.87%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
SBRA Yearly Profit, Operating, Gross MarginsSBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. SBRA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SBRA is destroying value.
  • The number of shares outstanding for SBRA has been increased compared to 1 year ago.
  • SBRA has more shares outstanding than it did 5 years ago.
  • SBRA has a worse debt/assets ratio than last year.
SBRA Yearly Shares OutstandingSBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SBRA Yearly Total Debt VS Total AssetsSBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.92, we must say that SBRA is in the distress zone and has some risk of bankruptcy.
  • SBRA has a better Altman-Z score (0.92) than 73.17% of its industry peers.
  • SBRA has a Debt/Equity ratio of 0.90. This is a neutral value indicating SBRA is somewhat dependend on debt financing.
  • SBRA has a better Debt to Equity ratio (0.90) than 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACC0.54
WACC7.18%
SBRA Yearly LT Debt VS Equity VS FCFSBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • SBRA has a Current Ratio of 1.48. This is a normal value and indicates that SBRA is financially healthy and should not expect problems in meeting its short term obligations.
  • SBRA has a better Current ratio (1.48) than 72.36% of its industry peers.
  • A Quick Ratio of 1.48 indicates that SBRA should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.48, SBRA is in the better half of the industry, outperforming 73.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
SBRA Yearly Current Assets VS Current LiabilitesSBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SBRA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.75% over the past year.
  • The Earnings Per Share has been decreasing by -0.91% on average over the past years.
  • SBRA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.15%.
  • SBRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.29% yearly.
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%

3.2 Future

  • Based on estimates for the next years, SBRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.55% on average per year.
  • Based on estimates for the next years, SBRA will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y19.53%
EPS Next 2Y12.21%
EPS Next 3Y9.55%
EPS Next 5YN/A
Revenue Next Year11.84%
Revenue Next 2Y10.45%
Revenue Next 3Y9.97%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SBRA Yearly Revenue VS EstimatesSBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
SBRA Yearly EPS VS EstimatesSBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. SBRA Valuation Analysis

4.1 Price/Earnings Ratio

  • SBRA is valuated quite expensively with a Price/Earnings ratio of 30.90.
  • Compared to the rest of the industry, the Price/Earnings ratio of SBRA indicates a somewhat cheap valuation: SBRA is cheaper than 66.67% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of SBRA to the average of the S&P500 Index (25.50), we can say SBRA is valued slightly more expensively.
  • A Price/Forward Earnings ratio of 25.85 indicates a quite expensive valuation of SBRA.
  • SBRA's Price/Forward Earnings ratio is rather cheap when compared to the industry. SBRA is cheaper than 82.93% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.67. SBRA is around the same levels.
Industry RankSector Rank
PE 30.9
Fwd PE 25.85
SBRA Price Earnings VS Forward Price EarningsSBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SBRA is valued a bit more expensive than the industry average as 65.04% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.48
SBRA Per share dataSBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.58
PEG (5Y)N/A
EPS Next 2Y12.21%
EPS Next 3Y9.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. SBRA Dividend Analysis

5.1 Amount

  • SBRA has a Yearly Dividend Yield of 5.93%, which is a nice return.
  • SBRA's Dividend Yield is a higher than the industry average which is at 7.32.
  • SBRA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 5.93%

5.2 History

  • The dividend of SBRA decreases each year by -2.44%.
  • SBRA has been paying a dividend for at least 10 years, so it has a reliable track record.
  • The dividend of SBRA decreased recently.
Dividend Growth(5Y)-2.44%
Div Incr Years0
Div Non Decr Years1
SBRA Yearly Dividends per shareSBRA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 186.04% of the earnings are spent on dividend by SBRA. This is not a sustainable payout ratio.
DP186.04%
EPS Next 2Y12.21%
EPS Next 3Y9.55%
SBRA Yearly Income VS Free CF VS DividendSBRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M
SBRA Dividend Payout.SBRA Dividend Payout, showing the Payout Ratio.SBRA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SBRA Fundamentals: All Metrics, Ratios and Statistics

SABRA HEALTH CARE REIT INC

NASDAQ:SBRA (3/25/2026, 10:57:09 AM)

19.775

+0.04 (+0.23%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners105.25%
Inst Owner Change6.77%
Ins Owners1.1%
Ins Owner Change6.9%
Market Cap4.99B
Revenue(TTM)774.63M
Net Income(TTM)155.61M
Analysts76
Price Target21.97 (11.1%)
Short Float %10%
Short Ratio8.88
Dividend
Industry RankSector Rank
Dividend Yield 5.93%
Yearly Dividend1.18
Dividend Growth(5Y)-2.44%
DP186.04%
Div Incr Years0
Div Non Decr Years1
Ex-Date02-13
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-44.68%
Min EPS beat(2)-51.75%
Max EPS beat(2)-37.61%
EPS beat(4)1
Avg EPS beat(4)-10.49%
Min EPS beat(4)-51.75%
Max EPS beat(4)51.26%
EPS beat(8)2
Avg EPS beat(8)-12.84%
EPS beat(12)2
Avg EPS beat(12)-37.62%
EPS beat(16)3
Avg EPS beat(16)-70.46%
Revenue beat(2)1
Avg Revenue beat(2)6.1%
Min Revenue beat(2)-0.25%
Max Revenue beat(2)12.46%
Revenue beat(4)3
Avg Revenue beat(4)3.96%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)12.46%
Revenue beat(8)7
Avg Revenue beat(8)2.98%
Revenue beat(12)8
Avg Revenue beat(12)2%
Revenue beat(16)10
Avg Revenue beat(16)1.09%
PT rev (1m)2.56%
PT rev (3m)3.38%
EPS NQ rev (1m)-2.62%
EPS NQ rev (3m)-7.15%
EPS NY rev (1m)-0.57%
EPS NY rev (3m)-2.91%
Revenue NQ rev (1m)6.44%
Revenue NQ rev (3m)5.46%
Revenue NY rev (1m)5.8%
Revenue NY rev (3m)2.93%
Valuation
Industry RankSector Rank
PE 30.9
Fwd PE 25.85
P/S 6.44
P/FCF N/A
P/OCF 14.3
P/B 1.77
P/tB 1.81
EV/EBITDA 16.48
EPS(TTM)0.64
EY3.24%
EPS(NY)0.77
Fwd EY3.87%
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)1.38
OCFY6.99%
SpS3.07
BVpS11.19
TBVpS10.93
PEG (NY)1.58
PEG (5Y)N/A
Graham Number12.69
Profitability
Industry RankSector Rank
ROA 2.83%
ROE 5.51%
ROCE 4.91%
ROIC 3.88%
ROICexc 3.93%
ROICexgc 3.98%
OM 34.06%
PM (TTM) 20.09%
GM 66.87%
FCFM N/A
ROA(3y)1.83%
ROA(5y)0.45%
ROE(3y)3.54%
ROE(5y)0.95%
ROIC(3y)3.71%
ROIC(5y)3.47%
ROICexc(3y)3.75%
ROICexc(5y)3.51%
ROICexgc(3y)3.78%
ROICexgc(5y)3.54%
ROCE(3y)4.7%
ROCE(5y)4.39%
ROICexgc growth 3Y5.81%
ROICexgc growth 5Y1.97%
ROICexc growth 3Y5.63%
ROICexc growth 5Y2.01%
OM growth 3Y-3.2%
OM growth 5Y-4.77%
PM growth 3YN/A
PM growth 5Y-2.77%
GM growth 3Y-4.64%
GM growth 5Y-4.04%
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA 5.61
Cap/Depr 242.22%
Cap/Sales 58.47%
Interest Coverage 2.38
Cash Conversion 77.32%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 0.92
F-Score5
WACC7.18%
ROIC/WACC0.54
Cap/Depr(3y)121.85%
Cap/Depr(5y)94.04%
Cap/Sales(3y)30%
Cap/Sales(5y)24.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.75%
EPS 3YN/A
EPS 5Y-0.91%
EPS Q2Q%-42.11%
EPS Next Y19.53%
EPS Next 2Y12.21%
EPS Next 3Y9.55%
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y7.43%
Revenue growth 5Y5.29%
Sales Q2Q%16.21%
Revenue Next Year11.84%
Revenue Next 2Y10.45%
Revenue Next 3Y9.97%
Revenue Next 5Y11.91%
EBIT growth 1Y2.66%
EBIT growth 3Y4%
EBIT growth 5Y0.26%
EBIT Next Year84.04%
EBIT Next 3Y26.83%
EBIT Next 5Y18.61%
FCF growth 1Y-159.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.26%
OCF growth 3Y3.36%
OCF growth 5Y-0.36%

SABRA HEALTH CARE REIT INC / SBRA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SABRA HEALTH CARE REIT INC (SBRA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SBRA.


Can you provide the valuation status for SABRA HEALTH CARE REIT INC?

ChartMill assigns a valuation rating of 2 / 10 to SABRA HEALTH CARE REIT INC (SBRA). This can be considered as Overvalued.


How profitable is SABRA HEALTH CARE REIT INC (SBRA) stock?

SABRA HEALTH CARE REIT INC (SBRA) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for SBRA stock?

The Earnings per Share (EPS) of SABRA HEALTH CARE REIT INC (SBRA) is expected to grow by 19.53% in the next year.


How sustainable is the dividend of SABRA HEALTH CARE REIT INC (SBRA) stock?

The dividend rating of SABRA HEALTH CARE REIT INC (SBRA) is 5 / 10 and the dividend payout ratio is 186.04%.